Literature DB >> 19712169

Helicobacter pylori infection in pediatrics.

Angelika Kindermann1, Ana I Lopes.   

Abstract

his review summarizes the articles published on Helicobacter pylori infection in children between April 2008 and March 2009. Recent evidence highlights the decreasing prevalence trend of H. pylori infection and supports both intrafamilial and extrafamilial transmission. The association with various symptoms is still being debated. Interestingly, H. pylori infection seems inversely associated with allergic diseases. Monoclonal stool antigen tests are widely used and accurate for the diagnosis of H. pylori infection, but less accurate in young children. The new biprobe real-time PCR assay applied to stools showed a poor sensitivity in children. Using the urea hydrolysis rate next to the delta over baseline values, the (13)C-urea breath test provides excellent results for all age children, even for young children. Treatment of H. pylori infection remains a challenge, considering suboptimal efficacy of current therapy. Among emerging alternatives, sequential treatment appears promising. The adjunction of probiotics to conventional regimens, although eliciting great interest, has shown limited therapeutic benefit.

Entities:  

Mesh:

Year:  2009        PMID: 19712169     DOI: 10.1111/j.1523-5378.2009.00700.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  9 in total

Review 1.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 2.  Helicobacter pylori infection in children: an overview of diagnostic methods.

Authors:  Parisa Sabbagh; Mostafa Javanian; Veerendra Koppolu; VeneelaKrishna Rekha Vasigala; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-07       Impact factor: 3.267

Review 3.  Helicobacter pylori persistence in children: distinguishing inadequate treatment, resistant organisms, and reinfection.

Authors:  Diana A Moya; Karen D Crissinger
Journal:  Curr Gastroenterol Rep       Date:  2012-06

4.  Probiotics and prebiotics in infants and children.

Authors:  Y Vandenplas; E De Greef; T Devreker; G Veereman-Wauters; B Hauser
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

5.  Helicobacter pylori in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based cross sectional survey.

Authors:  Elin Hestvik; Thorkild Tylleskar; Deogratias H Kaddu-Mulindwa; Grace Ndeezi; Lena Grahnquist; Edda Olafsdottir; James K Tumwine
Journal:  BMC Gastroenterol       Date:  2010-06-16       Impact factor: 3.067

6.  Prevalence of Helicobacter pylori in HIV-infected, HAART-naïve Ugandan children: a hospital-based survey.

Authors:  Elin Hestvik; Thorkild Tylleskar; Grace Ndeezi; Lena Grahnquist; Edda Olafsdottir; James K Tumwine; Deogratias H Kaddu-Mulindwa
Journal:  J Int AIDS Soc       Date:  2011-06-30       Impact factor: 5.396

7.  Investigation of Helicobacter pylori infection among symptomatic children in Hangzhou from 2007 to 2014: a retrospective study with 12,796 cases.

Authors:  Xiaoli Shu; Mingfang Ping; Guofeng Yin; Mizu Jiang
Journal:  PeerJ       Date:  2017-01-31       Impact factor: 2.984

8.  Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.

Authors:  Tita Butenko; Samo Jeverica; Rok Orel; Matjaž Homan
Journal:  Helicobacter       Date:  2017-06-27       Impact factor: 5.753

9.  Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Tomás Navarro-Rodriguez; Fernando Marcuz Silva; Ricardo Correa Barbuti; Rejane Mattar; Joaquim Prado Moraes-Filho; Maricê Nogueira de Oliveira; Cristina S Bogsan; Décio Chinzon; Jaime Natan Eisig
Journal:  BMC Gastroenterol       Date:  2013-03-26       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.